Navalign LLC’s Teladoc Health TDOC Stock Holding History

Navalign LLC’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8	Closed	-$56	–	432
2025 Q4	$56	Buy	+8	New	+$63	﹤0.01%	493

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Navalign LLC's TDOC Position: Q1 2026 in Review

Navalign LLC sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 8 shares — an estimated $56 sold.

Navalign LLC first reported a position in TDOC in Q4 2025 and held it in 1 quarter. The position peaked at $56 in Q4 2025. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

Navalign LLC reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
Navalign LLC sold 8 Teladoc Health shares in Q1 2026, an estimated $56.
Navalign LLC first reported a position in Teladoc Health in Q4 2025 and held it in 1 quarter.
Navalign LLC's Teladoc Health position peaked at $56 in Q4 2025.
323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Navalign LLC's 13F filing for Q1 2026, filed 29 Apr 2026.